NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX)

Lobbying client · Delaware · filed 2025 to 2026

Pharmaceutical company

$144,000 Reported spend

6 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (146958), not by name.

Firms hired 1

TWENTY-FIRST CENTURY GROUP, INC. $144,000 6 filings

Bills named in these filings 3

HR 8205
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

1 filing
HR 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

1 filing
HR 9495
Department of Defense Appropriations Act, 2027

1 filing

Reported by year 2 years

2026 $48,000 2 filings
2025 $96,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 6 total

Q2

TWENTY-FIRST CENTURY GROUP, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $24,000 income · posted Jul 20, 2026

View → Q1

TWENTY-FIRST CENTURY GROUP, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $24,000 income · posted Apr 17, 2026

View → Q4

TWENTY-FIRST CENTURY GROUP, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $24,000 income · posted Jan 19, 2026

View → Q3

TWENTY-FIRST CENTURY GROUP, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $24,000 income · posted Oct 19, 2025

View → Q2

TWENTY-FIRST CENTURY GROUP, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $24,000 income · posted Jul 18, 2025

View → Q1

TWENTY-FIRST CENTURY GROUP, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $24,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.